Poly ADP ribose polymerase (PARP) inhibition of cells containing a defect in homologous recombination pathways (e.g., those with BRCA1/2 mutations) results in the death of target tumor cells while sparing normal cells. The gene discussed is BRCA1; the disease is neoplasm.